Skip to main content

Hartig Drug Adds Nefense Nasal Care Family

By: Newsfile
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Dubuque, Iowa--(Newsfile Corp. - September 2, 2026) - Hartig Drug Company has expanded its product lineup by adding NefenseĀ® nasal care products at select locations in Iowa, Illinois, and Wisconsin, offering customers new drug-free options for daily nasal hygiene.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Hartig Drug Company adds Nefense nasal care products at select stores in Iowa, Illinois, and Wisconsin, making them available now to customers seeking drug-free options for daily nasal hygiene.
  • The Nefense lineup features hypochlorous acid nasal sprays for adults, children, and infants, plus a xylitol spray, providing non-medicated alternatives to decongestants across age groups.
  • Published randomized clinical research evaluates low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms and allergic rhinitis, although these studies do not test Nefense-branded products.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/312570_figure1_550.jpg

Click image above to view full announcement.


About Hartig Drug Company

Founded in Dubuque, Iowa, in 1904, Hartig Drug Company is a family-owned pharmacy and retail company serving communities throughout Iowa, Illinois and Wisconsin. Hartig Drug provides community pharmacy services along with health, wellness and everyday consumer products, with a continued focus on personalized service and strong local community relationships.

About Nefense

Nefense, Natural Wellness & Defense, is a Dubuque, Iowa-based nasal wellness company focused on daily nasal hygiene, airway care and better breathing. Developed under the direction of Richard Downs, DDS, the Nefense portfolio includes HypoNasal, HypoNasal Junior, HypoBaby and XyloClean, with hypochlorous acid and xylitol-based formulations designed for routine nasal care.

Learn more at nefense.com

Contacts:

Dan Simon
(563) 588-8700
dsimon@hartigdrug.com

Source: Newsworthy.ai

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/312570

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  257.58
-1.31 (-0.51%)
AAPL  321.29
-6.92 (-2.11%)
AMD  471.60
+15.44 (3.38%)
BAC  62.80
+0.08 (0.12%)
GOOG  335.48
-3.60 (-1.06%)
META  611.37
+0.69 (0.11%)
MSFT  500.44
-9.68 (-1.90%)
NVDA  230.17
+1.72 (0.75%)
ORCL  157.53
+3.49 (2.27%)
TSLA  353.23
-23.14 (-6.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.